GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly innovation in how we approach type 2 diabetes . These new therapies work by imitating the body’s inherent GLP-1 hormone , https://bookmark-group.com/story7498617/glp-1-a-major-breakthrough-in-glucose-care